Simultaneous targeting of EGFR , HER 2, and HER 4 by afatinib overcomes intrinsic and acquired cetuximab resistance in head and neck squamous cell carcinoma cell lines-Reference-Cited by-同舟云学术

Simultaneous targeting of EGFR , HER 2, and HER 4 by afatinib overcomes intrinsic and acquired cetuximab resistance in head and neck squamous cell carcinoma cell lines

Published:2018-05 Issue:6 Volume:12 Page:830-854
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

De Pauw Ines¹,Lardon Filip¹,Van den Bossche Jolien¹,Baysal Hasan¹,Fransen Erik²,Deschoolmeester Vanessa¹³,Pauwels Patrick¹³,Peeters Marc¹⁴,Vermorken Jan Baptist¹⁴,Wouters An¹

Affiliation:

1. Center for Oncological Research (CORE) University of Antwerp Wilrijk Belgium

2. StatUa Center for Statistics University of Antwerp Belgium

3. Department of Pathology Antwerp University Hospital Edegem Belgium

4. Department of Medical Oncology Antwerp University Hospital Edegem Belgium

Funder

Universiteit Antwerpen

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.12197

Reference87 articles.

1. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma;Ang KK;Can Res,2002

2. EGFR and RB1 as Dual Biomarkers in HPV-Negative Head and Neck Cancer

3. Anti-Epidermal Growth Factor Receptor Therapy in Head and Neck Squamous Cell Carcinoma: Focus on Potential Molecular Mechanisms of Drug Resistance

4. Establishment and characterization of cetuximab resistant head and neck squamous cell carcinoma cell lines: focus on the contribution of the AP‐1 transcription factor;Boeckx C;Am J Cancer Res,2015

5. Overcoming cetuximab resistance in HNSCC: The role of AURKB and DUSP proteins

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. miR-424-5p suppresses the proliferation and immigration of oral squamous cell carcinoma via down-regulation of KDR;Aging;2024-08-26

2. Phenotypic switching as a non-genetic mechanism of resistance predicts antibody therapy regimens;iScience;2024-04

3. Acrolein suppresses anticancer drug-induced toxicity mediated by activating claudin-1 and Nrf2 axis in a spheroid model of human lung squamous cell carcinoma cells;Toxicology Letters;2024-02

4. Multi-kinase compensation rescues EGFR knockout in a cell line model of head and neck squamous cell carcinoma;Archives of Oral Biology;2023-12

5. Establishment of head and neck squamous cell carcinoma mouse models for cetuximab resistance and sensitivity;Cancer Drug Resistance;2023-10-17